United Kingdom Insulin Infusion Pump Market Insight
Published: 18 July 2026 | Report Format: Electronic (PDF) | Author: Komal and Radhika
The United Kingdom Insulin Infusion Pump Market was valued at USD 0.31 Billion in 2025 and is projected to reach USD 0.61 Billion by 2035, expanding at a CAGR of 7.01% during the forecast period. Market growth is supported by the rising prevalence of Type 1 diabetes, increasing adoption of continuous insulin delivery systems, favorable NHS reimbursement policies, growing integration of continuous glucose monitoring (CGM) with insulin pumps, and continuous technological advancements in automated insulin delivery devices.
United Kingdom Insulin Infusion Pump Market Forecasts to 2035
- The United Kingdom Insulin Infusion Pump Market Size was estimated at USD 0.31 Billion in 2025.
- The market is expected to grow at a CAGR of 7.01% from 2025 to 2035.
- The market is projected to reach approximately USD 0.61 Billion by 2035.
Notable Insights for the United Kingdom Insulin Infusion Pump Market
- Segmentation Based on Product Type, Durable Insulin Pumps accounted for the largest market share of approximately 68.4% in 2025, driven by their long service life, advanced connectivity features, and widespread adoption among patients requiring intensive insulin therapy.
- Segmentation Based on End User, Hospitals & Diabetes Clinics represented nearly 56.9% of total market revenue in 2025, supported by specialist diabetes care programs, structured insulin pump training, and increasing referrals for advanced diabetes management.
- Medtronic plc reported USD 33.54 Billion in revenue during fiscal 2025, supported by continued demand for MiniMed insulin pump systems, integrated diabetes management technologies, expanding digital health capabilities, and sustained investments in innovative diabetes care solutions.
Download the eBook (ToC)
- Insulet Corporation generated approximately USD 2.18 Billion in revenue during fiscal 2025, driven by growing global adoption of the Omnipod insulin delivery platform, expanding reimbursement coverage, increasing patient preference for tubeless pumps, and continued commercial expansion.
Research Methodologies Used to Analyze the United Kingdom Insulin Infusion Pump Market
This study combines primary and secondary research methodologies to evaluate the United Kingdom Insulin Infusion Pump Market. Primary research includes interviews with endocrinologists, diabetes specialists, hospital procurement managers, insulin pump manufacturers, distributors, healthcare professionals, NHS representatives, and industry executives. Secondary research incorporates company annual reports, NHS publications, Diabetes UK reports, MHRA regulatory data, industry journals, trade associations, and commercial market intelligence databases. Market estimates are developed using top-down and bottom-up approaches, while data triangulation ensures reliable market sizing, competitive benchmarking, and long-term forecasting accuracy.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Insulin Infusion Pump Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Insulin Infusion Pump Market
- Medtronic plc
- Insulet Corporation
- Tandem Diabetes Care, Inc.
- Roche Diabetes Care
- Ypsomed AG
- Abbott Laboratories
- Dexcom, Inc.
- B. Braun SE
- SOOIL Development Co., Ltd.
- Terumo Corporation.
Recent Developments:
- In September 2025, Medtronic plc launched an enhanced MiniMed insulin infusion pump platform across selected European markets, including the United Kingdom, featuring improved automated insulin delivery algorithms and expanded CGM integration for diabetes management.
- In April 2025, Ypsomed AG collaborated with Abbott Laboratories to strengthen interoperability between the mylife insulin pump ecosystem and FreeStyle Libre continuous glucose monitoring technology, improving connected diabetes care solutions for UK patients.
Market Segmentation
United Kingdom Insulin Infusion Pump Market, By Product Type
- Durable Insulin Pumps
- Disposable Insulin Pumps
United Kingdom Insulin Infusion Pump Market, By Application
- Type 1 Diabetes
- Type 2 Diabetes
United Kingdom Insulin Infusion Pump Market, By End User
- Hospitals & Diabetes Clinics
- Home Care Settings
- Ambulatory Care Centers
- Others
United Kingdom Insulin Infusion Pump Market, By Distribution Channel
- Direct Sales
- Retail Pharmacies
- Online Sales
United Kingdom Insulin Infusion Pump Market, By Region
- England
- Scotland
- Wales
- Northern Ireland
Expert Views:
The United Kingdom Insulin Infusion Pump Market is expected to witness sustained growth through 2035 as diabetes management increasingly shifts toward connected and automated care. Companies investing in smart insulin delivery platforms, integrated CGM compatibility, digital health ecosystems, and collaborative healthcare partnerships are likely to strengthen their market position while improving patient outcomes and long-term treatment adherence.
Author: Komal and Radhika By Decisions Advisors and Consulting